Samuel P. Dickson

2.5k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Samuel P. Dickson is a scholar working on Physiology, Genetics and Molecular Biology. According to data from OpenAlex, Samuel P. Dickson has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Samuel P. Dickson's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Genetic Associations and Epidemiology (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Samuel P. Dickson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Genetic Associations and Epidemiology (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Samuel P. Dickson collaborates with scholars based in United States, United Kingdom and Canada. Samuel P. Dickson's co-authors include David B. Goldstein, Håkon Håkonarson, Ian D. Krantz, Kai Wang, Catherine A. Stolle, Suzanne Hendrix, Jessica M. Maia, Erin L. Heinzen, Dongliang Ge and Mingfu Zhu and has published in prestigious journals such as Bioinformatics, Neurology and PLoS Biology.

In The Last Decade

Samuel P. Dickson

25 papers receiving 1.0k citations

Hit Papers

Rare Variants Create Synthetic Genome-Wide Associations 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rare Variants Create Synthetic Genome-Wide Associations
    2010 611 citations Samuel P. Dickson, Kai Wang et al. PLoS Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel P. Dickson United States 10 623 374 101 64 54 29 1.0k
Steven Andrew Baker United States 15 597 1.0× 670 1.8× 65 0.6× 37 0.6× 55 1.0× 29 1.1k
Sarah A. Gagliano Taliun Canada 12 530 0.9× 396 1.1× 142 1.4× 20 0.3× 70 1.3× 37 1.2k
Kaanan P. Shah United States 4 702 1.1× 706 1.9× 69 0.7× 23 0.4× 102 1.9× 5 1.1k
Sahar V. Mozaffari United States 7 691 1.1× 689 1.8× 65 0.6× 21 0.3× 113 2.1× 7 1.1k
Bin Cai China 18 261 0.4× 316 0.8× 64 0.6× 22 0.3× 53 1.0× 54 944
Arno Ruusalepp Estonia 15 446 0.7× 630 1.7× 82 0.8× 36 0.6× 159 2.9× 26 1.1k
Kristin K. Nicodemus United States 8 175 0.3× 561 1.5× 149 1.5× 34 0.5× 63 1.2× 8 1.1k
Kenji Ohe Japan 21 309 0.5× 669 1.8× 82 0.8× 15 0.2× 93 1.7× 74 1.3k
Laura Almasy United States 11 630 1.0× 353 0.9× 240 2.4× 54 0.8× 34 0.6× 12 1.2k
Béatrice Gouyon France 17 416 0.7× 957 2.6× 193 1.9× 62 1.0× 24 0.4× 40 1.9k

Countries citing papers authored by Samuel P. Dickson

Since Specialization
Citations

This map shows the geographic impact of Samuel P. Dickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel P. Dickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel P. Dickson more than expected).

Fields of papers citing papers by Samuel P. Dickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel P. Dickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel P. Dickson. The network helps show where Samuel P. Dickson may publish in the future.

Co-authorship network of co-authors of Samuel P. Dickson

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel P. Dickson. A scholar is included among the top collaborators of Samuel P. Dickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel P. Dickson. Samuel P. Dickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
LʼItalien, G., Lauren Powell, Michele Potashman, et al.. (2025). Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease. Neurology and Therapy. 14(4). 1609–1625.
3.
4.
Phan, H., Ayesha Ahmad, Janet A. Thomas, et al.. (2024). Results of the ACTION‐Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia. The Journal of Clinical Pharmacology. 65(5). 575–587. 1 indexed citations
5.
Dickson, Samuel P., Benjamin Haaland, Craig Mallinckrodt, et al.. (2024). “Time Saved” Calculations to Improve Decision-Making in Progressive Disease Studies. The Journal of Prevention of Alzheimer s Disease. 11(3). 529–536. 8 indexed citations
6.
Dickson, Samuel P., Craig Mallinckrodt, Michele Potashman, et al.. (2024). Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying Therapies. Neurology and Therapy. 13(6). 1627–1639. 2 indexed citations
7.
Bristow, Claire, Tatum D. Mortimer, Sheldon Morris, et al.. (2023). Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae. The Journal of Infectious Diseases. 227(7). 917–925. 5 indexed citations
8.
Wessels, Alette M., Ellen B. Dennehy, Sherie A. Dowsett, Samuel P. Dickson, & Suzanne Hendrix. (2023). Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings. Neurology Clinical Practice. 13(2). e200127–e200127. 19 indexed citations
9.
Yu, Hui Jing, Samuel P. Dickson, Pei‐Ning Wang, et al.. (2023). Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study. EBioMedicine. 94. 104665–104665. 32 indexed citations
10.
Dickson, Samuel P., et al.. (2023). Avoiding future controversies in the Alzheimer’s disease space through understanding the aducanumab data and FDA review. Alzheimer s Research & Therapy. 15(1). 11 indexed citations
11.
Hendrix, Suzanne, et al.. (2023). Time saved in disease progression for treatments in AD (including 3 monoclonal antibodies and 2 other promising treatments). Alzheimer s & Dementia. 19(S24). 2 indexed citations
12.
Dickson, Samuel P., et al.. (2022). The CDR‐SB and other clinical trial mistakes made due to regulatory momentum. Alzheimer s & Dementia. 18(S10). 1 indexed citations
13.
Moebius, Hans J., Charles Bernick, Paul Winner, et al.. (2022). ACT‐AD: Fosgonimeton in mild‐to‐moderate Alzheimer’s disease – first results of a randomized, placebo‐controlled, 26‐week Phase 2 proof‐of‐concept trial. Alzheimer s & Dementia. 18(S10). 3 indexed citations
14.
Hendrix, Suzanne, Robin Mogg, Klaus Romero, et al.. (2021). Perspectives on Statistical Strategies for the Regulatory Biomarker Qualification Process. Biomarkers in Medicine. 15(9). 669–684. 8 indexed citations
15.
Long, Nanye, et al.. (2013). Leveraging Prior Information to Detect Causal Variants via Multi-Variant Regression. PLoS Computational Biology. 9(6). e1003093–e1003093. 8 indexed citations
16.
Zhu, Qianqian, Dongliang Ge, Erin L. Heinzen, et al.. (2012). Prioritizing Genetic Variants for Causality on the Basis of Preferential Linkage Disequilibrium. The American Journal of Human Genetics. 91(3). 422–434. 17 indexed citations
17.
Zhu, Qianqian, Dongliang Ge, Jessica M. Maia, et al.. (2011). A Genome-wide Comparison of the Functional Properties of Rare and Common Genetic Variants in Humans. The American Journal of Human Genetics. 88(4). 458–468. 69 indexed citations
18.
Ge, Dongliang, Elizabeth K. Ruzzo, Kevin V. Shianna, et al.. (2011). SVA: software for annotating and visualizing sequenced human genomes. Bioinformatics. 27(14). 1998–2000. 46 indexed citations
19.
Dickson, Samuel P., Kai Wang, Ian D. Krantz, Håkon Håkonarson, & David B. Goldstein. (2010). Rare Variants Create Synthetic Genome-Wide Associations. PLoS Biology. 8(1). e1000294–e1000294. 611 indexed citations breakdown →
20.
Wang, Kai, Samuel P. Dickson, Catherine A. Stolle, et al.. (2010). Interpretation of Association Signals and Identification of Causal Variants from Genome-wide Association Studies. The American Journal of Human Genetics. 86(5). 730–742. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Andrew Baker Breakdown of academic impact, for papers by Sarah A. Gagliano Taliun Breakdown of academic impact, for papers by Kaanan P. Shah Breakdown of academic impact, for papers by Sahar V. Mozaffari Breakdown of academic impact, for papers by Bin Cai Breakdown of academic impact, for papers by Arno Ruusalepp Breakdown of academic impact, for papers by Kristin K. Nicodemus Breakdown of academic impact, for papers by Kenji Ohe Breakdown of academic impact, for papers by Laura Almasy Breakdown of academic impact, for papers by Béatrice Gouyon
Rankless by CCL
2026